Mounjaro® Online
Connect with a licensed provider to discuss Mounjaro and other GLP-1 treatments. Online consultation, no insurance required.
GLP-1 treatment plans
Plans starting as low as
Pricing reflects compounded GLP-1 treatment. Branded Mounjaro pricing varies.
- Dual-action GLP-1/GIP medication FDA-approved for type 2 diabetes
- Weekly subcutaneous injection
- Doctor-prescribed after online consultation
- Compounded tirzepatide alternatives available
- No insurance, no membership fees
- Free expedited shipping
Mounjaro® (tirzepatide) is an FDA-approved dual GLP-1/GIP receptor agonist developed by Eli Lilly for the treatment of type 2 diabetes. It’s prescribed weekly as a subcutaneous injection. Mounjaro contains the same active ingredient as Zepbound® (tirzepatide) but is dosed and indicated for blood sugar control rather than chronic weight management. At Provn, a licensed provider can review your medical history and determine whether Mounjaro, compounded tirzepatide, or another GLP-1 treatment is appropriate for you. Branded Mounjaro and compounded tirzepatide are not the same medication — your provider will explain the differences and help you decide what fits your goals and budget.
What’s included with my plan?
Your plan includes an online consultation with a licensed U.S. provider, your prescription if approved, your medication shipped in plain packaging with free expedited delivery, and ongoing access to your provider for follow-up questions or dose adjustments throughout treatment.
What weight loss treatment options are available to me?
Provn connects you with licensed providers who may prescribe compounded tirzepatide, compounded semaglutide, or other GLP-1 treatments based on your medical history and goals. Your provider will discuss whether branded Mounjaro, a compounded alternative, or another approach is right for you.
What if I need to cancel?
Plans are month-to-month with no long-term commitment. You can cancel through your account dashboard or by contacting our support team at any time.
The statements on this page have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
FSA & HSA eligible
Customized to your needs
Free shipping with all plans
Trusted brands
Start your weight loss journey
Care that knows your name
FSA & HSA eligible
Customized to your needs
Free shipping with all plans
Trusted brands
Start your weight loss journey
Care that knows your name
It’s not about willpower, it's about science backed results
Mounjaro® and other GLP-1 medications work on the biology of hunger and metabolism, not your discipline. Tirzepatide, the active ingredient in Mounjaro, acts on two hormone pathways your body already uses — GLP-1 and GIP — to regulate blood sugar, slow digestion, and reduce appetite. For many patients, that dual-action biological support is what makes managing type 2 diabetes and overall metabolic health possible.
Submit your application and meet with a doctor
The process is entirely online and takes about three minutes to start. Complete a short medical questionnaire covering your health history, current medications, and treatment goals. A licensed U.S. physician will review your information and, if a GLP-1 treatment is appropriate, issue your prescription. If they need additional information, they'll reach out directly.
Get your medication delivered at home
If your provider prescribes a GLP-1 medication, your prescription ships directly to your door in plain, unmarked, temperature-controlled packaging. Free expedited delivery is included with every plan. No pharmacy lines, no insurance paperwork, no waiting rooms — just your treatment, delivered fast.
Stay supported with 24/7 access and ongoing care
Treatment isn't a one-time event — it's an ongoing process. Throughout your treatment, you'll have access to your provider for dose adjustments, side effect questions, or general check-ins. Many patients also benefit from coaching, nutrition guidance, and community support, which can be added to your plan as part of a more comprehensive approach to long-term metabolic health.
Compounded tirzepatide: a more accessible alternative.
For patients who can't access branded Mounjaro — whether due to cost, insurance, or supply — compounded tirzepatide may be an option. Our licensed providers can discuss whether it's right for you.
Discover other medication to hit your health goals
Provn connects patients with licensed providers who may prescribe medication through state-licensed pharmacies. Prescription medication is only available if prescribed after an online consultation with a licensed healthcare provider. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Provn is not affiliated with, endorsed by, or sponsored by Eli Lilly. Mounjaro is FDA-approved for the treatment of type 2 diabetes and is not approved by the FDA for weight loss. Compounded medications are not FDA approved and are not reviewed by the FDA for safety or effectiveness. Compounded tirzepatide is not the same as branded Mounjaro. Statements on this page have not been evaluated by the Food and Drug Administration. Individual results may vary. Plans are offered as a subscription service which you can cancel at any time. Actual product packaging may appear differently than shown.
FAQs
Is this real Mounjaro®?
Mounjaro® is a branded medication manufactured by Eli Lilly. Provn connects you with licensed providers who can prescribe Mounjaro if it’s the right fit and available, or compounded tirzepatide as an alternative. Your provider will discuss the differences and help you decide what’s appropriate for your situation.
What's the difference between Mounjaro and compounded tirzepatide?
Mounjaro is an FDA-approved branded medication produced by Eli Lilly for the treatment of type 2 diabetes. Compounded tirzepatide contains the same active ingredient (tirzepatide) but is prepared by a state-licensed compounding pharmacy. Compounded medications are not FDA approved. Branded and compounded versions may differ in dosing, formulation, and price. Your provider can walk you through the comparison.
What's the difference between Mounjaro and Zepbound?
Mounjaro and Zepbound both contain tirzepatide and are made by Eli Lilly. The difference is in their FDA-approved indications: Mounjaro is approved for type 2 diabetes, while Zepbound is approved for chronic weight management in adults with obesity or overweight with weight-related conditions. The two medications are dosed differently. Your provider can explain which is appropriate for your situation.
How does tirzepatide work?
Tirzepatide (the active ingredient in Mounjaro) is a dual GLP-1 and GIP receptor agonist. It mimics two hormones your body produces naturally that help regulate blood sugar, slow how quickly your stomach empties, and influence appetite. The dual-pathway action distinguishes tirzepatide from semaglutide-based medications, which work on GLP-1 alone.
Who is eligible for treatment?
A licensed provider determines eligibility based on your medical history, current medications, blood sugar levels, and overall health goals. GLP-1 medications aren’t right for everyone — your provider will let you know if you’re a candidate or recommend an alternative if you aren’t.
What are the most common side effects?
The most common side effects of tirzepatide are gastrointestinal — nausea, diarrhea, constipation, and reduced appetite — and are usually most noticeable when starting treatment or increasing the dose. Most patients find these effects diminish as the body adjusts. More serious side effects include pancreatitis, gallbladder issues, kidney problems, and changes in vision. Tell your provider about any unusual symptoms, and seek immediate care for severe abdominal pain, persistent vomiting, or signs of an allergic reaction.
Do I need a prescription?
Yes. Both Mounjaro and compounded tirzepatide are prescription-only. Provn connects you with a licensed U.S. physician who reviews your medical history and determines if treatment is appropriate. The consultation is online and takes only a few minutes.
Mounjaro® is a registered trademark of Eli Lilly and Company. Provn is not affiliated with, endorsed by, or sponsored by Eli Lilly. This page is provided for educational and comparison purposes only. Mounjaro is FDA-approved for the treatment of type 2 diabetes in adults. Mounjaro is NOT FDA-approved for chronic weight management. For weight management, the FDA-approved tirzepatide product is Zepbound®. For patients seeking access to tirzepatide through Provn, our licensed providers may prescribe compounded tirzepatide through state-licensed compounding pharmacies based on individual clinical evaluation. Compounded tirzepatide is not FDA-approved. Compounded medications are prepared by state-licensed pharmacies and are not reviewed by the FDA for safety or effectiveness. Individual results may vary.
